Covance Inc. News Headlines

CVD 
$83.2375
*  
0.4225
0.51%
Get CVD Alerts
*Delayed - data as of Aug. 29, 2014 15:47 ET  -  Find a broker to begin trading CVD now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CVD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Covance Retains Balanced View on Steady Growth - Analyst Blog
8/22/2014 6:15:00 PM - Zacks.com

Contract Researcher Parexel Sees Growth In Biotech
8/21/2014 3:00:00 PM - Investor's Business Daily

Parexel - Best CRO, But Wait For A Better Moment
8/11/2014 10:24:00 AM - Seeking Alpha

Hunting For Bears
8/9/2014 9:16:00 AM - Seeking Alpha

Covance Earnings Beat, Revenues Meet Estimates, View Tweaked - Analyst Blog
7/31/2014 3:10:00 PM - Zacks.com

Covance Q2 14 Earnings Conference Call; Webcast At 9:30 A.m. ET
7/30/2014 9:03:00 AM - RTT News

Covance Q2 Profit Tops Estimate
7/29/2014 4:30:00 PM - RTT News

Soaring Indian Coronary Stent Market Puts These Stocks in Focus - Analyst Blog
7/2/2014 4:57:00 PM - Zacks.com

Covance To Present At William Blair Growth Conference; Webcast At 9:00 AM ET
6/11/2014 8:00:00 AM - RTT News

Covance Expands in Market Access - Analyst Blog
5/20/2014 5:40:00 PM - Zacks.com

Covance Posts In-line Q1 Earnings; Falls on Trimmed View - Analyst Blog
5/8/2014 3:30:00 PM - Zacks.com

Charles River Beats on Earnings, Guidance Upped - Analyst Blog
5/1/2014 3:34:01 PM - Zacks.com

MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
5/1/2014 4:03:00 AM - Investopedia

Covance (CVD) is now in Oversold Territory - Tale of the Tape
4/30/2014 7:19:01 AM - Zacks.com

Charles River Laboratories: A Well-Positioned CRO Due To Blossom In Pre-Clinical Services
4/29/2014 3:26:00 PM - Seeking Alpha

Covance (CVD) Shares Cross Below 200 DMA
4/28/2014 11:16:50 AM - BNK Invest

Must-know catalysts and valuation for ICON
4/4/2014 1:00:00 PM - Market Realist

Why analyst expectation of a margin compression is unreasonable
4/4/2014 9:00:00 AM - Market Realist

Market overview for CROs suggest healthy growth for ICON
4/3/2014 4:22:00 PM - Market Realist

ICON could benefit from ongoing secular shift to outsourcing of clinical trials services
4/3/2014 12:21:00 PM - Market Realist

Covance Crafts New 52-Week High - Analyst Blog
3/21/2014 10:30:01 AM - Zacks.com

Coverage on Covance Initiated - Analyst Blog
3/6/2014 4:20:01 PM - Zacks.com

Covance Inc (CVD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
3/6/2014 8:00:01 AM - Zacks.com

MedAssets Beats on Q4 Earnings, Shares Up - Analyst Blog
3/5/2014 11:45:01 AM - Zacks.com

Omnicare Earnings Rise but Miss Estimates - Analyst Blog
2/20/2014 1:30:01 PM - Zacks.com